The Pilatus PC-21 training aircraft for Canada has completed factory testing in Switzerland.
1 89217
A landmark event for the Royal Canadian Air Force took place in Stans, Switzerland. The first Pilatus PC-21, designated CT-157 Siskin II (which translates as "Goldfinch"), passed factory acceptance testing. This means that Canada's next-generation trainer is ready for service in Canada.
Acceptance trials included a comprehensive check of the aircraft's systems, avionics, and overall build quality. Earlier, on February 26, the aircraft completed its first flight tests.
The Pilatus PC-21 is a two-seat, low-wing, turboprop aircraft. It is powered by a Pratt & Whitney Canada PT6A-68B engine producing 1600 horsepower. It has a top speed of 425 mph (685 km/h), a ceiling of 38,500 feet (11580 meters), and a range of 813 miles (1333 kilometers). It is equipped with avionics capable of simulating combat systems. Canada plans to replace its aging fleet with these aircraft as part of the FAcT (Flight of the Aircrew Training) program. The contract calls for the purchase of 19 aircraft.
Canada's first Goldfinch has already been painted in a yellow and blue livery. Canadian cadets will now train on these aircraft. Ottawa hopes these pilots will one day climb into the cockpit of an F-35.
Development of the Pilatus PC-21 began in 1999. The first prototype was produced three years later, and it also performed its maiden flight. Subsequently, the aircraft were built, including for export – as of 2024, they are in use in Spain and France. Previous orders have included the UAE, Singapore, Saudi Arabia, Qatar, Australia, and Jordan. Now it's Canada's turn.
Dear reader, to leave comments on the publication, you must sign in.
Right Sector (banned in Russia), Ukrainian Insurgent Army (UPA) (banned in Russia), ISIS (banned in Russia), Jabhat Fatah al-Sham formerly Jabhat al-Nusra (banned in Russia), Al-Qaeda (banned in Russia), Anti-Corruption Foundation (banned in Russia), Navalny Headquarters (banned in Russia), Facebook (banned in Russia), Instagram (banned in Russia), Meta (banned in Russia), Misanthropic Division (banned in Russia), Azov (banned in Russia), Muslim Brotherhood (banned in Russia), Aum Shinrikyo (banned in Russia), AUE (banned in Russia), UNA-UNSO (banned in of Russia), the Mejlis of the Crimean Tatar People (banned in Russia), the Freedom of Russia Legion (an armed formation recognized as terrorist in the Russian Federation and banned), Kirill Budanov (included in the list of terrorists and extremists of Rosfinmonitoring), the International LGBT Public Movement and its structural divisions recognized as extremist (decision of the Supreme Court of the Russian Federation dated 30.11.2023/XNUMX/XNUMX), Hayat Tahrir al-Sham (recognized as a terrorist organization by the Supreme Court of the Russian Federation)
"Non-profit organizations, unregistered public associations or individuals performing the functions of a foreign agent", as well as media outlets performing the functions of a foreign agent: Meduza; Voice of America; Realii; Current Time; Radio Liberty; Ponomarev Lev; Ponomarev Ilya; Savitskaya; Markelov; Kamalyagin; Apakhonchich; Makarevich; Dud; Gordon; Zhdanov; Medvedev; Fedorov; Mikhail Kasyanov; Dmitry Muratov; Mikhail Khodorkovsky; Sova; Alliance of Doctors; RCC; Levada Center; Memorial; Voice; Man and Law; Dozhd; Mediazona; Deutsche Welle; Caucasian Knot News Media Center; Insider; "Novaya Gazeta", "Non-profit organizations, unregistered public associations or individuals performing the functions of a foreign agent", as well as media outlets performing the functions of a foreign agent: "Meduza"; "Voice of America"; "Realities"; "Current Time"; "Radio Liberty"; Ponomarev Lev; Ponomarev Ilya; Savitskaya; Markelov; Kamalyagin; Apakhonchich; Makarevich; Dud; Gordon; Zhdanov; Medvedev; Fedorov; Mikhail Kasyanov; Dmitry Muratov; Mikhail Khodorkovsky; "Sova"; "Alliance of Doctors"; "RKK" "Levada Center"; "Memorial"; "Voice"; "Man and Law"; "Dozhd"; "Mediazona"; "Deutsche Welle"; "Caucasian Knot"; "Insider"; "Novaya Gazeta"; "Carnegie Endowment"
Information